Cambrex Reschedules Third Quarter 2012 Financial Results and Earnings Call
Date to November 5, 2012
EAST RUTHERFORD, N.J., Oct. 31, 2012
EAST RUTHERFORD, N.J., Oct. 31, 2012 /PRNewswire/ -- Due to complications
from the storm affecting the East Coast, Cambrex Corporation (NYSE: CBM,
"Cambrex") will now report its results of the third quarter ended September
30, 2012 after the market closes Monday, November 5, 2012
The Company will also host a conference call to discuss the financial results
Monday, November 5, 2012 at 4:45 p.m. EST.
Third Quarter 2012 Earnings Conference Call
When: Monday, November 5, 2012 at 4:45 p.m. Eastern Time
Dial-in: 1-888-430-8705 for U.S.
1-719-325-2455 for International
Dial-in Replay: 1-888-203-1112 for U.S.
1-719-457-0820 for International
Available through Monday, November 12, 2012
Cambrex Corporation is an innovative life sciences company that provides
products, services and technologies to accelerate the development and
commercialization of small molecule therapeutics. We offer Active
Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug
delivery products for branded and generic pharmaceuticals. Our development and
manufacturing capabilities include enzymatic biotransformations, high potency
APIs, high energy chemical synthesis, controlled substances and formulation of
finished dosage form products. For more information, please visit
SOURCE Cambrex Corporation
Contact: Stephanie LaFiura, Investor Relations Associate, +1-201-804-3037,
Press spacebar to pause and continue. Press esc to stop.